Journal of Cancer Therapeutics and Research

Journal of Cancer Therapeutics and Research

ISSN 2049-7962
Original Research

Volasertib (BI 6727), a novel polo-like kinase inhibitor, reverses ABCB1 and ABCG2-mediated multidrug resistance in cancer cells

Kenneth K.W. To1*, Daniel C. Poon1, X.G. Chen2 and L.W. Fu2

*Correspondence: Kenneth K.W. To kennethto@cuhk.edu.hk

1. School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.


Journal of Cancer Therapeutics and Research  2013 2:13doi: 10.7243/2049-7962-2-13

No comments have yet been made on this article.
Volume 2
Full text Download
Order Reprints
View Metrics